DLH Conducting Trials and Leading Studies Related to COVID-19
July 21 2020 - 8:00AM
DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the
“Company”), a leading provider of innovative healthcare
research, services and solutions to federal agencies, today
announced that it has recently been awarded multiple task orders
and contracts related to COVID-19 testing and analysis that are
expected to add at least $15 million of incremental revenue, with
the majority anticipated in calendar 2020. The task orders
encompass the evaluation of various treatment alternatives and the
impact of COVID-19 on other chronic conditions, as well as the
development of health communication tools to exchange emerging data
among numerous scientific stakeholders. These efforts are being
performed for the U.S. Department of Health and Human Services.
“DLH has supported the National Institutes of
Health and the Centers for Disease Control and Prevention for
decades in the fight against infectious diseases, and we are proud
to continue in the current effort addressing COVID-19,” said DLH
President and Chief Executive Officer Zach Parker. “As the National
Institute for Allergy and Infectious Diseases continues to lead the
national response to finding vaccines and therapeutics to combat
this novel coronavirus pandemic, DLH will draw on its contract
research organization (CRO) expertise, leveraging clinical research
services to establish a platform to rapidly evaluate multiple
therapeutic products. Through these recent awards, we will leverage
our epidemiological and clinical trials expertise and manage a
consortium of partners to secure the necessary patients and conduct
clinical trials to achieve success in the battle against this
pandemic.” About
DLHDLH (NASDAQ: DLHC) serves federal government clients
throughout the United States and abroad delivering technology
enabled solutions in key health and human services programs. The
Company's core competencies include secure data analytics, clinical
trials and laboratory services, case management, performance
evaluation, system modernization, operational logistics and
readiness, and strategic digital communications. DLH has over 1,950
employees serving numerous government agencies. For more
information, visit the corporate website at www.dlhcorp.com
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995:This press
release may contain forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. These
statements relate to future events or DLH`s future financial
performance. Any statements that refer to expectations,
projections or other characterizations of future events or
circumstances or that are not statements of historical fact
(including without limitation statements to the effect that the
Company or its management “believes”, “expects”, “anticipates”,
“plans”, “intends” and similar expressions) should be considered
forward looking statements that involve risks and uncertainties
which could cause actual events or DLH’s actual results to differ
materially from those indicated by the forward-looking statements.
Forward-looking statements in this release include, among others,
statements regarding estimates of future revenues. These statements
reflect our belief and assumptions as to future events that may not
prove to be accurate. Our actual results may differ materially from
such forward-looking statements made in this release due to a
variety of factors, including: the outbreak of the novel
coronavirus (“COVID-19”), including the measures to reduce its
spread, and its impact on the economy and demand for our services,
are uncertain, cannot be predicted, and may precipitate or
exacerbate other risks and uncertainties; the risk that we will not
realize the anticipated benefits of an acquisition; the challenges
of managing larger and more widespread operations resulting from
the acquisition; contract awards in connection with re-competes for
present business and/or competition for new business; compliance
with new bank financial and other covenants; changes in client
budgetary priorities; government contract procurement (such as bid
protest, small business set asides, loss of work due to
organizational conflicts of interest, etc.) and termination risks;
the ability to successfully integrate the operations of future
acquisitions; and other risks described in our SEC filings. For a
discussion of such risks and uncertainties which could cause actual
results to differ from those contained in the forward-looking
statements, see “Risk Factors” in the Company’s periodic reports
filed with the SEC, including our Annual Report on Form 10-K for
the fiscal year ended September 30, 2019, as well as subsequent
reports filed thereafter. The forward-looking statements contained
herein are not historical facts, but rather are based on current
expectations, estimates, assumptions and projections about our
industry and business. Such forward-looking statements are
made as of the date hereof and may become outdated over time. The
Company does not assume any responsibility for updating
forward-looking statements, except as may be required by law.
CONTACTS:
INVESTOR RELATIONSContact: Chris
WittyPhone: 646-438-9385Email:
cwitty@darrowir.com
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Apr 2024 to May 2024
DLH (NASDAQ:DLHC)
Historical Stock Chart
From May 2023 to May 2024